Literature DB >> 9115247

Scanning alanine mutagenesis and de-peptidization of a Candida albicans myristoyl-CoA:protein N-myristoyltransferase octapeptide substrate reveals three elements critical for molecular recognition.

C A McWherter1, W J Rocque, M E Zupec, S K Freeman, D L Brown, B Devadas, D P Getman, J A Sikorski, J I Gordon.   

Abstract

Candida albicans produces a single myristoyl-CoA:protein N-myristoyltransferase (Nmt) that is essential for its viability. An ADP-ribosylation factor (Arf) is included among the few cellular protein substrates of this enzyme. An octapeptide (GLYASKLS-NH2) derived from a N-terminal Arf sequence was used as the starting point to identify elements critical for recognition by the acyltransferases's peptide-binding site. In vitro kinetic studies, employing purified Nmt and a panel of peptides with single Ala substitutions at each position of GLYASKLS-NH2, established that its Gly1, Ser5, and Lys6 residues play predominant roles in binding. ALYASKLS-NH2 was found to be an inhibitor competitive for peptide (Ki = 15.3 +/- 6.4 microM) and noncompetitive for myristoyl-CoA (Ki = 31.2 +/- 0.7 microM). A survey of 26 derivatives of this inhibitor, representing (i) a complete alanine scan, (ii) progressive C-terminal truncations, and (iii) manipulation of the physical-chemical properties of its residues 1, 5, and 6, confirmed the important stereochemical requirements for the N-terminal amine, the beta-hydroxyl of Ser5, and the epsilon-amino group of Lys6. Remarkably, replacement of the the N-terminal tetrapeptide of ALYASKLS-NH2 with an 11-aminoundecanoyl group produced a competitive inhibitor, 11-aminoundecanoyl-SKLS-NH2, that was 38-fold more potent (Ki = 0.40 +/- 0.03 microM) than the starting octapeptide. Removing the primary amine (undecanoyl-SKLS-NH2), or replacing it with a methyl group (dodecanoyl-SKLS-NH2), resulted in 26- and 34-fold increases in IC50, confirming the important contribution of the amine to recognition. Removal of LeuSer from the C terminus (11-aminoundecanoyl-SK-NH2) yielded a competitive dipeptide inhibitor with a Ki (11.7 +/- 0.4 microM) equivalent to that of the starting octapeptide, ALYASKLS-NH2. Substitution of Ser with homoserine, cis-4-hydroxyproline, or tyrosine reduces potency by 3-70-fold, emphasizing the requirement for proper presentation of the hydroxyl group in the dipeptide inhibitor. Substituting D- for L-Lys decreases its inhibitory activity >100-fold, while deletion of the epsilon-amino group (Nle) or masking its charge (epsilon-N-acetyl-lysine) produces 4-7-fold attenuations. L-His, but not its D-isomer, can fully substitute for L-Lys, producing a competitive dipeptide inhibitor with similar potency (Ki = 11.9 +/- 1.0 microM). 11-Aminoundecanoyl-SK-NH2 and 11-aminoundecanoyl-SH-NH2 establish that a simple alkyl backbone can maintain an appropriate distance between three elements critical for recognition by the fungal enzyme's peptide-binding site: a simple omega-terminal amino group, a beta-hydroxyl, and an epsilon-amino group or an imidazole. These compounds contain one peptide bond and two chiral centers, suggesting that it may be feasible to incorporate these elements of recognition, or functionally equivalent mimics, into a fully de-peptidized Nmt inhibitor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115247     DOI: 10.1074/jbc.272.18.11874

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.

Authors:  Chrysoula Panethymitaki; Paul W Bowyer; Helen P Price; Robin J Leatherbarrow; Katherine A Brown; Deborah F Smith
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

2.  Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum.

Authors:  Paul W Bowyer; Ruwani S Gunaratne; Munira Grainger; Chrislaine Withers-Martinez; Sasala R Wickramsinghe; Edward W Tate; Robin J Leatherbarrow; Katherine A Brown; Anthony A Holder; Deborah F Smith
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

3.  Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.

Authors:  Stephen Brand; Laura A T Cleghorn; Stuart P McElroy; David A Robinson; Victoria C Smith; Irene Hallyburton; Justin R Harrison; Neil R Norcross; Daniel Spinks; Tracy Bayliss; Suzanne Norval; Laste Stojanovski; Leah S Torrie; Julie A Frearson; Ruth Brenk; Alan H Fairlamb; Michael A J Ferguson; Kevin D Read; Paul G Wyatt; Ian H Gilbert
Journal:  J Med Chem       Date:  2011-12-07       Impact factor: 7.446

4.  Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.

Authors:  Andrew S Bell; James E Mills; Gareth P Williams; James A Brannigan; Anthony J Wilkinson; Tanya Parkinson; Robin J Leatherbarrow; Edward W Tate; Anthony A Holder; Deborah F Smith
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

5.  N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.

Authors:  James A Brannigan; Barbara A Smith; Zhiyong Yu; Andrzej M Brzozowski; Michael R Hodgkinson; Asher Maroof; Helen P Price; Franziska Meier; Robin J Leatherbarrow; Edward W Tate; Deborah F Smith; Anthony J Wilkinson
Journal:  J Mol Biol       Date:  2009-12-28       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.